---
schema_version: "secwatch.filing_event.v1"
accession: "0001213900-26-040111"
form_type: "8-K"
ticker: "PFSA"
cik: "0001859807"
company_name: "Profusa, Inc."
filed_at: "2026-04-06T23:59:59+00:00"
generated_at: "2026-05-15T07:25:53.234906+00:00"
event_type: "m_and_a"
sentiment: "neutral"
materiality_score: 0.8
confidence: "high"
source: SEC EDGAR
---

# Profusa signs LOI to buy PanOmics assets for $30M equity; issues $555k convertible note

## Summary
- Non-binding LOI to acquire Bio Insights' PanOmics assay for $30M in stock (460k common + 59.54M conversion shares) plus 3% annual net revenue royalty.
- Issued $555,556 senior secured convertible note to Ascent (12% interest, due 2027, convertible at $0.50) and warrant for 1.11M shares at $0.50.
- Amendment No. 4 allows up to $12.2M additional notes with at least 10% OID; $1.67M principal release condition.
- Acquisition requires shareholder vote by June 30, 2026 and $10M equity financing within 30 days post-closing.
- Bio Insights gets one board nominee; management retention shares (12% fully diluted) for CEO/CFO.

## SEC filing metadata
- accession: 0001213900-26-040111
- form_type: 8-K
- ticker: PFSA
- cik: 0001859807
- company_name: Profusa, Inc.
- filed_at: 2026-04-06T23:59:59+00:00
- event_type: m_and_a
- sentiment: neutral
- materiality_score: 0.8
- confidence: high
- sec_items: 1.01, 2.03, 3.02, 8.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1859807/000121390026040111/0001213900-26-040111-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1859807/000121390026040111/ea0285151-8k_profusa.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001213900-26-040111
- JSON: https://secwatch.observer/filing/0001213900-26-040111.json
- Plain text: https://secwatch.observer/filing/0001213900-26-040111.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.